SecBot SecBot
SECBOTREPLAY Home › Report › VERA

VERA · Four C-suite executives at Vera Therapeutics, including CEO Fordyce…

Vera Therapeutics, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Four C-suite executives at Vera Therapeutics, including CEO Fordyce Marshall, sold shares in a coordinated open-market transaction on February 23, 2026, totaling approximately $977,000 in value. All sales were conducted at the same price, indicating a planned divestment during a single trading day.

  • CEO Fordyce Marshall sold 16,925 shares for $710,577.51 in open-market transaction.
  • Three other C-suite officers (Chief Regulatory, Chief Operating, and Chief Commercial Officers) collectively sold 6,348 shares for $266,514.78.
  • All transactions occurred on the same day at the same price ($41.9839), suggesting coordination.
  • Total insider selling cluster value: $977,092.29 in open-market sales.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access